RecruitingNot ApplicableNCT05209841

Heparinization vs Salinization of the Peripheral Venous Catheter

Heparinization vs Salinization of the Peripheral Venous Catheter: a Randomized Clinical Trial

Sponsor

Consorci Sanitari de l'Alt Penedès i Garraf

Enrollment

3,450 participants

Start Date

Apr 5, 2022

Study Type

INTERVENTIONAL

Conditions

Catheter Complications

Summary

Randomized, double-blind clinical trial to compare the efficacy of catheter sealing with saline, compared to low-dose heparin. 3,450 patients hospitalized at the Hospital Residencia Sant Camil, in Catalonia (Spain), will be randomized to each branch of study. The primary outcome will be the percentage of catheters removed due to obstruction in each branch of study. As secondary outcomes, the number of catheter-associated phlebitis, catheter-associated bacetrihemia, extravasation, and catheter loss will be measured. For the primary outcome, a superiority analysis will be carried out in terms of the percentage of obstructed catheters in each branch of the study.

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Low dose heparin and a drug called Normal saline for people with catheter complications. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.